ZA975828B - Stable medicament for oral administration and method for its production. - Google Patents

Stable medicament for oral administration and method for its production.

Info

Publication number
ZA975828B
ZA975828B ZA9705828A ZA975828A ZA975828B ZA 975828 B ZA975828 B ZA 975828B ZA 9705828 A ZA9705828 A ZA 9705828A ZA 975828 A ZA975828 A ZA 975828A ZA 975828 B ZA975828 B ZA 975828B
Authority
ZA
South Africa
Prior art keywords
oral administration
production
resistant
core
gastric juice
Prior art date
Application number
ZA9705828A
Inventor
Gerd-Ulfert Heese
Herbert Juenger
Arnim Laicher
Claudio Lorck
Thomas Profitlich
Gerd Weiss
Peter Wolfegg
Original Assignee
Klinge Co Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Klinge Co Chem Pharm Fab filed Critical Klinge Co Chem Pharm Fab
Publication of ZA975828B publication Critical patent/ZA975828B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Abstract

The invention relates to a stable drug form which is for oral administration and comprises: (a) a core comprising one or more active ingredients which are not to be released until after they have passed through the stomach, together with conventional pharmaceutical adjuvants, (b) an intermediate layer applied to the core, and (c) an external layer which is resistant to gastric juice. The intermediate layer in (b) is in the form of a reactive layer comprising a polymeric layered material which is partly neutralised with alkalis, is resistant to gastric juice and has cation-exchanger capacity. A process for the preparation of the stable drug form is also disclosed.
ZA9705828A 1996-06-28 1997-06-30 Stable medicament for oral administration and method for its production. ZA975828B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19626045A DE19626045C2 (en) 1996-06-28 1996-06-28 A stable dosage form for oral administration containing omeprazole as the active ingredient and methods of making the same

Publications (1)

Publication Number Publication Date
ZA975828B true ZA975828B (en) 1998-01-30

Family

ID=7798347

Family Applications (2)

Application Number Title Priority Date Filing Date
ZA9705828A ZA975828B (en) 1996-06-28 1997-06-30 Stable medicament for oral administration and method for its production.
ZA9705827A ZA975827B (en) 1996-06-28 1997-06-30 Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ZA9705827A ZA975827B (en) 1996-06-28 1997-06-30 Stable medicament with benzimidazole derivatives as an active ingredient for oral administration and method for its production.

Country Status (11)

Country Link
EP (1) EP0934058B1 (en)
JP (1) JP4641075B2 (en)
AT (1) ATE247457T1 (en)
AU (2) AU3438897A (en)
CA (1) CA2258918C (en)
DE (2) DE19626045C2 (en)
DK (1) DK0934058T3 (en)
ES (1) ES2205243T3 (en)
PT (1) PT934058E (en)
WO (2) WO1998000115A2 (en)
ZA (2) ZA975828B (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
SE9704869D0 (en) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
UA73092C2 (en) * 1998-07-17 2005-06-15 Брістол-Майерс Сквібб Компані Tablets with enteric coating and method for their manufacture
JP4988088B2 (en) 1998-08-12 2012-08-01 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Oral dosage form composition of pyridin-2-ylmethylsulfinyl-1H-benzimidazole, a compound having a skeleton of pyridin-2-ylmethylsulfinyl-1H-benzimidazole, or a pharmaceutically acceptable salt thereof is fixed. Composition combined with
DE19845358A1 (en) * 1998-10-02 2000-04-06 Roehm Gmbh Coated drug forms with controlled drug delivery
IL130602A0 (en) 1999-06-22 2000-06-01 Dexcel Ltd Stable benzimidazole formulation
US6420473B1 (en) * 2000-02-10 2002-07-16 Bpsi Holdings, Inc. Acrylic enteric coating compositions
AR030557A1 (en) 2000-04-14 2003-08-27 Jagotec Ag A TABLET IN MULTI-MAP OF CONTROLLED RELEASE AND TREATMENT METHOD
US7316819B2 (en) * 2001-03-08 2008-01-08 Unigene Laboratories, Inc. Oral peptide pharmaceutical dosage form and method of production
KR100479637B1 (en) * 2002-02-01 2005-03-31 한국화학연구원 Oral dosage form comprising Lansoprazole and preparation method for the same
CA2494716A1 (en) 2002-08-02 2004-02-19 Ratiopharm Gmbh Pharmaceutical preparation containing a benzimidazole compound mixed with microcrystalline cellulose and a method for its preparation
DE10235475B4 (en) * 2002-08-02 2006-04-27 Ratiopharm Gmbh Medicaments containing a benzimidazole compound in admixture with microcrystalline cellulose and process for their preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
AR045068A1 (en) * 2003-07-23 2005-10-12 Univ Missouri FORMULATION OF IMMEDIATE RELEASE OF PHARMACEUTICAL COMPOSITIONS
RU2351315C2 (en) * 2003-07-24 2009-04-10 Смитклайн Бичам Корпорейшн Films, dissolving in mouth cavity
JPWO2005084649A1 (en) * 2004-03-04 2007-11-29 武田薬品工業株式会社 Stable capsule
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20090208575A1 (en) * 2005-01-03 2009-08-20 Lupin Limited Pharmaceutical Composition Of Acid Labile Substances
DE102005032806A1 (en) * 2005-07-12 2007-01-18 Röhm Gmbh Use of a partially neutralized, anionic (meth) acrylate copolymer as a coating for the preparation of a dosage form with a release of active ingredient at reduced pH values
DE102006006532B4 (en) * 2006-02-10 2007-11-08 Biogenerics Pharma Gmbh Pharmaceutical preparation
US9597293B2 (en) * 2007-05-07 2017-03-21 Evonik Röhm Gmbh Solid dosage forms comprising an enteric coating with accelerated drug release
DE102008056312A1 (en) 2008-11-07 2010-05-12 Biogenerics Pharma Gmbh Use of micro-tablets as food and feed additive
DE102010052847A1 (en) * 2010-11-29 2012-05-31 Temmler Werke Gmbh Process for the preparation of a PPI-containing pharmaceutical preparation
US8951996B2 (en) * 2011-07-28 2015-02-10 Lipocine Inc. 17-hydroxyprogesterone ester-containing oral compositions and related methods
WO2014136494A1 (en) * 2013-03-08 2014-09-12 富士フイルム株式会社 Enteric-coated fine particle and drug composition
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
BR112020020783A2 (en) * 2018-04-12 2021-01-26 Bpsi Holdings, Llc acidifying coatings and disintegration resistant substrates coated with the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
JPS584730A (en) * 1981-06-29 1983-01-11 Shin Etsu Chem Co Ltd Enteric coating composition and its preparation
GB2189698A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated omeprazole tablets
DE3822095A1 (en) * 1988-06-30 1990-01-04 Klinge Co Chem Pharm Fab NEW MEDICAMENT FORMULATION AND METHOD FOR THE PRODUCTION THEREOF
IT1230576B (en) * 1988-10-20 1991-10-28 Angeli Inst Spa ORAL PHARMACEUTICAL FORMULATIONS WITH SELECTIVE LIBERATION IN THE COLON
US5225202A (en) * 1991-09-30 1993-07-06 E. R. Squibb & Sons, Inc. Enteric coated pharmaceutical compositions
AU4513393A (en) * 1992-07-17 1994-02-14 Astra Aktiebolag Pharmaceutical composition containing antiulcer agent
JPH0733659A (en) * 1992-07-17 1995-02-03 Yoshitomi Pharmaceut Ind Ltd Antiulcer agent-containing pharmaceutical preparation
SE9302395D0 (en) * 1993-07-09 1993-07-09 Ab Astra NEW PHARMACEUTICAL FORMULATION

Also Published As

Publication number Publication date
JP2000514051A (en) 2000-10-24
ES2205243T3 (en) 2004-05-01
CA2258918C (en) 2005-11-22
JP4641075B2 (en) 2011-03-02
DK0934058T3 (en) 2003-12-01
CA2258918A1 (en) 1998-01-08
WO1998000114A3 (en) 1998-02-26
EP0934058B1 (en) 2003-08-20
DE59710629D1 (en) 2003-09-25
AU3345197A (en) 1998-01-21
ATE247457T1 (en) 2003-09-15
DE19626045C2 (en) 1998-12-03
EP0934058A2 (en) 1999-08-11
WO1998000115A2 (en) 1998-01-08
WO1998000114A2 (en) 1998-01-08
DE19626045A1 (en) 1998-01-08
AU3438897A (en) 1998-01-21
WO1998000115A3 (en) 1998-02-26
PT934058E (en) 2004-01-30
ZA975827B (en) 1998-01-30

Similar Documents

Publication Publication Date Title
ZA975828B (en) Stable medicament for oral administration and method for its production.
GEP20033014B (en) Enteric Coated Pharmaceutical Composition and Method of Manufacturing
AU531280B2 (en) Cardiac glycoside composition
DE58906926D1 (en) New drug formulation and process for its manufacture.
MY102675A (en) Pharmaceutical formulations of acid labile substances for oral use.
ES2006649A6 (en) Composition for the oral administration of pharmaceuticals
CA2232356A1 (en) Method of producing multi-layer medicaments in solid form for oral or rectal administration
IE881916L (en) Press-coated dihydropyridine tablets
IT1245761B (en) PHARMACEUTICAL FORMULATIONS CONTAINING GLYCOSAMINOGLICANS ABSORBABLE ORALLY.
NZ322053A (en) Controlled release pharmaceutical formulation comprising an active, a low MW polyethylene oxide, HPMC and one or more enteric polymers
CA2219991A1 (en) Taste masking pharmaceutical composition for oral administration
WO2002005829A3 (en) Methods and formultations with probiotic microorganisms and medicaments
HUT59306A (en) Process for producing pharmaceutical compositions comprising l-carnitine
MX9500885A (en) Pharmaceutical preparation for oral administration.
CA2274910A1 (en) Flat medicament preparation for the application and release of buprenorphine or a pharmacologically comparable substance in the buccal cavity, and method of producing the same
WO1999007401A3 (en) The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases
NO992944L (en) Active ingredient for the delivery of apomorphine in the oral cavity
GR1002847B (en) Use of micropostol and/or micropostol acid for the preparation of a medicine for the therapeutic treatiment of problems related to the erection
NO890186L (en) PROCEDURE FOR THE PREPARATION OF A DELIVERY AND / OR DOSAGE FORM FOR MEDICINAL ACTIVE SUBSTANCES.
WO2000008007A3 (en) Cyclopentabenzofuran derivatives and their use
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
EP0302714A3 (en) Pharmaceutical composition for treatment of bone-wasting diseases
EP0271151A3 (en) Azumolene dosage form
GR3034646T3 (en) Substituted benzenesulfonylureas and -thioureas, process for their preparation, their use in the production of pharmaceutical preparations and medicaments containing them
NO326141B1 (en) Procedure for the treatment of isolated systolic hypertension